Nicotine in these recent arrivals can be either synthetic or ... Thus, the paper advocates for “stronger FDA regulation of tobacco product manufacturing [and] the design and marketing of these ...
The End-of-Phase 2 meeting resulted in alignment with the FDA on the proposed Phase 3 study design, including the inclusion/exclusion criteria, primary and secondary efficacy objectives, definition of ...
Results that may be inaccessible to you are currently showing.